A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy

Clinical trial NCT01610492 · COMPLETED

Trial details

NCT number: NCT01610492
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glomerulonephritis, Membranous

Start date: 2012-07-01
Primary completion: 2014-09-24
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.